Suppr超能文献

采用能量限制饮食和低碳水化合物饮食等不同饮食疗法的日本糖尿病肾病成年患者的肾功能轨迹:一项回顾性队列研究。

Renal function trajectories of Japanese adults with diabetic kidney disease on different diet therapies including energy-restricted and low-carbohydrate diets: a retrospective cohort study.

作者信息

Shirai Tomomi, Inaba Sakiko, Maemura Miyu, Saho Maki, Sato Miyu, Sanada Mariko, Tsukamoto Yoko, Inoue Gaku, Nagahisa Taichi, Tanaka Shinichi, Tanaka Hajime, Kurata Hideaki, Katsuki Takeshi, Kawai Toshihide, Yamada Satoru

机构信息

Diabetes Center, Kitasato University Kitasato Institute Hospital, 5-9-1 Shirokane, Minato-Ku, Tokyo, 108-0072 Japan.

Department of Food and Nutritional Science, Graduate School of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-Ku, Tokyo, 156-8502 Japan.

出版信息

Diabetol Int. 2025 Mar 21;16(3):493-503. doi: 10.1007/s13340-025-00808-y. eCollection 2025 Jul.

Abstract

OBJECTIVE

Recently, the Japan Diabetes Society changed its nutrition recommendations and now recognizes a low-carbohydrate diet as an effective dietary approach. There has been controversy regarding low-carbohydrate diets in relation to renal function. That is, high protein intake may lead to renal damage through hyperfiltration. Global nutritional therapy for diabetic kidney disease (DKD) recommends a protein intake of 0.8 g/kg body weight (BW)/day. In Japan, the recommended protein intake is precisely determined based on the chronic kidney disease stage. However, evidence supporting the positive health impact of such protein restriction is scarce. Therefore, we aimed to investigate the effect of a low-carbohydrate diet without protein restriction on the estimated glomerular filtration rate (eGFR) decline rate.

METHODS

Clinical data of patients with DKD in Tokyo Saiseikai Central Hospital and Kitasato Institute Hospital in Japan were retrospectively analyzed between February 2019 and December 2023. Sixty-eight participants were classified into two groups based on their diet: the energy-restricted and low-carbohydrate groups.

RESULTS

The protein intake of the low-carbohydrate group was significantly higher than that of the energy-restricted group (1.2 ± 0.4 and 1.0 ± 0.2 g/kg BW/day, respectively). No significant differences were observed in the baseline, endpoint, or slope of eGFR between the two groups.

CONCLUSIONS

This study suggests that among Japanese adults with DKD, the protein intake difference between energy-restricted and low-carbohydrate diets does not form any gap in eGFR decline rates.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13340-025-00808-y.

摘要

目的

最近,日本糖尿病学会更改了其营养建议,现在认可低碳水化合物饮食是一种有效的饮食方法。关于低碳水化合物饮食与肾功能的关系一直存在争议。也就是说,高蛋白摄入可能通过超滤导致肾损伤。糖尿病肾病(DKD)的全球营养治疗建议蛋白质摄入量为0.8克/千克体重/天。在日本,推荐的蛋白质摄入量是根据慢性肾脏病阶段精确确定的。然而,支持这种蛋白质限制对健康产生积极影响的证据很少。因此,我们旨在研究不限制蛋白质的低碳水化合物饮食对估计肾小球滤过率(eGFR)下降率的影响。

方法

回顾性分析了2019年2月至2023年12月期间日本东京济生会中央医院和北里研究所医院DKD患者的临床资料。68名参与者根据其饮食被分为两组:能量限制组和低碳水化合物组。

结果

低碳水化合物组的蛋白质摄入量显著高于能量限制组(分别为1.2±0.4和1.0±0.2克/千克体重/天)。两组之间的eGFR基线、终点或斜率均未观察到显著差异。

结论

本研究表明,在患有DKD的日本成年人中,能量限制饮食和低碳水化合物饮食之间的蛋白质摄入量差异在eGFR下降率方面没有形成任何差距。

补充信息

在线版本包含可在10.1007/s13340-025-00808-y获取的补充材料。

相似文献

2
Protein restriction for diabetic kidney disease.
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2.
3
Nutritional interventions for survivors of childhood cancer.
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
4
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
5
Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.
Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD013334. doi: 10.1002/14651858.CD013334.pub2.
6
Altered dietary salt intake for preventing diabetic kidney disease and its progression.
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
7
Advice on low-fat diets for obesity.
Cochrane Database Syst Rev. 2002(2):CD003640. doi: 10.1002/14651858.CD003640.
8
WITHDRAWN: Advice on low-fat diets for obesity.
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD003640. doi: 10.1002/14651858.CD003640.pub2.
9
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

本文引用的文献

1
Kidney outcomes with SGLT2 inhibitor versus DPP4 inhibitor use in older adults with diabetes.
Nephrol Dial Transplant. 2025 Feb 28;40(3):495-504. doi: 10.1093/ndt/gfae158.
2
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
3
Dietary Protein Restriction in Patients with Chronic Kidney Disease.
N Engl J Med. 2024 Jan 4;390(1):86-89. doi: 10.1056/NEJMclde2304134.
4
Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease.
Endocrinol Metab (Seoul). 2023 Feb;38(1):43-55. doi: 10.3803/EnM.2022.1629. Epub 2023 Feb 27.
5
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
Kidney Int. 2022 Nov;102(5S):S1-S127. doi: 10.1016/j.kint.2022.06.008.
7
Hypertension and the kidneys.
Br J Hosp Med (Lond). 2022 May 2;83(5):1-11. doi: 10.12968/hmed.2021.0440. Epub 2022 May 27.
8
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease.
Curr Diab Rep. 2022 Jan;22(1):39-52. doi: 10.1007/s11892-021-01442-z. Epub 2022 Feb 3.
9
Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study.
Clin Chem. 2022 Mar 4;68(3):461-472. doi: 10.1093/clinchem/hvab249.
10
KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update.
Am J Kidney Dis. 2020 Sep;76(3 Suppl 1):S1-S107. doi: 10.1053/j.ajkd.2020.05.006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验